Comparative Pharmacology
Head-to-head clinical analysis: FULVICIN P G 165 versus MONISTAT DUAL PAK.
Peer-Reviewed Evidence
Head-to-head clinical analysis: FULVICIN P G 165 versus MONISTAT DUAL PAK.
FULVICIN P/G 165 vs MONISTAT DUAL- PAK
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Griseofulvin binds to and disrupts microtubule function by inhibiting spindle formation and mitosis in dermatophytes, leading to inhibition of fungal cell division.
Miconazole, an imidazole antifungal, inhibits fungal cytochrome P450 14α-demethylase, reducing ergosterol synthesis and disrupting fungal cell membrane integrity. Tioconazole, also an imidazole, similarly inhibits ergosterol synthesis.
165 mg orally once daily.
Intravaginal: One applicatorful of 6.5% miconazole nitrate cream (1200 mg) at bedtime as a single dose. Topical: Apply 2% miconazole nitrate cream to affected area twice daily for 2 weeks.
None Documented
None Documented
Terminal elimination half-life is approximately 9-24 hours; dependent on formulation and absorption rate. Steady-state achieved within 4-5 days.
The terminal elimination half-life of miconazole following intravenous administration is approximately 24 hours (range 20-30 hours). This supports once-daily dosing for systemic infections, though topical application yields negligible systemic absorption.
Primarily renal excretion of metabolites; <1% excreted unchanged. Biliary/fecal elimination accounts for ~30% of metabolites.
Approximately 90% of an absorbed dose is eliminated in feces as unchanged drug and metabolites; less than 1% is excreted renally as unchanged drug. Biliary excretion is the primary route for the absorbed fraction.
Category C
Category C
Antifungal
Antifungal